230 related articles for article (PubMed ID: 31999670)
1. Drugs for ADHD.
Med Lett Drugs Ther; 2020 Jan; 62(1590):9-15. PubMed ID: 31999670
[No Abstract] [Full Text] [Related]
2. Jornay PM -- evening-dosed methylphenidate for ADHD.
Med Lett Drugs Ther; 2019 Aug; 61(1578):126-128. PubMed ID: 31386648
[No Abstract] [Full Text] [Related]
3. Azstarys (serdexmethylphenidate/dexmethylphenidate) for ADHD.
Med Lett Drugs Ther; 2021 Oct; 63(1634):157-159. PubMed ID: 34550957
[No Abstract] [Full Text] [Related]
4. A new amphetamine oral suspension (Adzenys ER) for ADHD.
Med Lett Drugs Ther; 2018 Jun; 60(1549):e106-e108. PubMed ID: 29913476
[No Abstract] [Full Text] [Related]
5. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
6. A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.
Pelham WE; Aronoff HR; Midlam JK; Shapiro CJ; Gnagy EM; Chronis AM; Onyango AN; Forehand G; Nguyen A; Waxmonsky J
Pediatrics; 1999 Apr; 103(4):e43. PubMed ID: 10103335
[TBL] [Abstract][Full Text] [Related]
7. Advances in the treatment of attention-deficit/hyperactivity disorder: a guide for pediatric neurologists.
Wigal SB; Chae S; Patel A; Steinberg-Epstein R
Semin Pediatr Neurol; 2010 Dec; 17(4):230-6. PubMed ID: 21183129
[TBL] [Abstract][Full Text] [Related]
8. Managing stimulant medication for attention-deficit/hyperactivity disorder.
Wender EH
Pediatr Rev; 2001 Jun; 22(6):183-90. PubMed ID: 11389305
[No Abstract] [Full Text] [Related]
9. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
Cortese S; Adamo N; Del Giovane C; Mohr-Jensen C; Hayes AJ; Carucci S; Atkinson LZ; Tessari L; Banaschewski T; Coghill D; Hollis C; Simonoff E; Zuddas A; Barbui C; Purgato M; Steinhausen HC; Shokraneh F; Xia J; Cipriani A
Lancet Psychiatry; 2018 Sep; 5(9):727-738. PubMed ID: 30097390
[TBL] [Abstract][Full Text] [Related]
10. [Stimulant and non-stimulant medication in current and future therapy for ADHD].
Franke AG; Konrad A; Lieb K; Huss M
Fortschr Neurol Psychiatr; 2012 Mar; 80(3):130-40. PubMed ID: 21611939
[TBL] [Abstract][Full Text] [Related]
11. In brief: Alternatives to Adderall.
Med Lett Drugs Ther; 2022 Nov; 64(1664):191-192. PubMed ID: 36397191
[No Abstract] [Full Text] [Related]
12. Evaluation of the current data on guanfacine extended release for the treatment of ADHD in children and adolescents.
Childress A; Hoo-Cardiel A; Lang P
Expert Opin Pharmacother; 2020 Mar; 21(4):417-426. PubMed ID: 31971448
[No Abstract] [Full Text] [Related]
13. Pharmacology of adult ADHD with stimulants.
Spencer TJ
CNS Spectr; 2007 Apr; 12(4 Suppl 6):8-11. PubMed ID: 17715564
[No Abstract] [Full Text] [Related]
14. Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts.
Stein MA; Waldman ID; Charney E; Aryal S; Sable C; Gruber R; Newcorn JH
J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):581-8. PubMed ID: 22136094
[TBL] [Abstract][Full Text] [Related]
15. α2-Adrenergic Agonists or Stimulants for Preschool-Age Children With Attention-Deficit/Hyperactivity Disorder.
Harstad E; Shults J; Barbaresi W; Bax A; Cacia J; Deavenport-Saman A; Friedman S; LaRosa A; Loe IM; Mittal S; Tulio S; Vanderbilt D; Blum NJ
JAMA; 2021 May; 325(20):2067-2075. PubMed ID: 33946100
[TBL] [Abstract][Full Text] [Related]
16. Focalin XR for ADHD.
Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
[No Abstract] [Full Text] [Related]
17. The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications.
Swanson JM; Lerner M; Wigal T; Steinhoff K; Greenhill L; Posner K; Freid J; Wigal S
J Atten Disord; 2002; 6 Suppl 1():S73-88. PubMed ID: 12685522
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis.
Marchetti A; Magar R; Lau H; Murphy EL; Jensen PS; Conners CK; Findling R; Wineburg E; Carotenuto I; Einarson TR; Iskedjian M
Clin Ther; 2001 Nov; 23(11):1904-21. PubMed ID: 11768842
[TBL] [Abstract][Full Text] [Related]
19. Retrospective comparison of Adderall and methylphenidate in the treatment of attention deficit hyperactivity disorder.
Grcevich S; Rowane WA; Marcellino B; Sullivan-Hurst S
J Child Adolesc Psychopharmacol; 2001; 11(1):35-41. PubMed ID: 11322743
[TBL] [Abstract][Full Text] [Related]
20. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
